Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (3854)	7/1/1998 3:35:00 PM
From: Dixie7777	Respond to of 9523

****This Post is Somewhat Off-Topic***** For those of you that have been interested in the biotech field and especially emerging opportunities, you may wish to review the following. Obviously your own DD will always be the only measure of a worthy investment. With that said, there are many of us that would like to introduce you to Sanguine. Very possibly the best kept secret in its field. It is the only product of its kind with a history of live trials that proved its efficacy. (You must read the thread for the research and conduct your own DD.) All other candidates to date have either fallen away with too high a mortality rate, or have severe limitations that will probably inhibit their marketability. Sanguine has had ZERO mortality rate in its live trials. We also believe that this "secret" is about to emerge into the mainstream with recognition by a major investment banking firm and a potential major pharmaceutical suitor. Started By: Profiteer Date: May 20 1998 6:28PM ET SANGUINE CORP. (SGNC) Due to the overwhelming renewed interest in (SGNC), this thread should be helpful as a forum for Information & Discussion. SANGUINE CORP. (SGNC) a California corporation is engaged in the development of a synthetic red blood cell product called "PHER-02." Management believes the PHER-02 has advantages over human blood: ú It can be sterilized to be free of disease including (HIV.) ú is believed to have the quality of a universal match for all blood types: ú can be mass-produced. ú may be stored much longer than human blood. Sanguine estimates the annual market potential for this product at $20 billion. Dr. Thomas C. Drees: Company President & Chief Executive Officer The most recent post at the time of copying this info is, https://www.siliconinvestor.com/readmsg.aspx?msgid=5075776

To: VLAD who wrote (3854)	7/8/1998 6:21:00 PM
From: hilm	Respond to of 9523

vlad<< The point is that Viagra is a systemic drug and MUSE acts locally. Also the substance in MUSE is already produced naturally by the body where as Viagra is not an endogenous chemical. I think that Viagra is fine with otherwise healthy men who want a boost or who have psychogenic ED. But when it comes to men with underlying health problems (especially those on high blood pressure meds) I strongly question Viagra's safety.>> Vlad, 1) while Muse works locally it can produce a vaso-vagal response, with subsequent fainting episode. I had a patient in the office who literally went down after an insertion of a muse capsule. He would have hit the floor if I hadn't caught him. So administration local, response systemic. 2) you are concerned with saftey. Fair enough. Don't use it. For the rest of the world they can go on the studies done which in my humble opinion prove its safety. hilm